Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
As of today, Halozyme Therapeutics(HALO) shares are valued at $71.21. The company's market cap stands at 8.37B, with a P/E ratio of 15.10.
On 2026-01-16, Halozyme Therapeutics(HALO) stock traded between a low of $70.78 and a high of $71.84. Shares are currently priced at $71.21, which is +0.6% above the low and -0.9% below the high.
Halozyme Therapeutics(HALO) shares are trading with a volume of 1.25M, against a daily average of 2.13M.
During the past year, Halozyme Therapeutics(HALO) stock moved between $47.50 at its lowest and $79.50 at its peak.
During the past year, Halozyme Therapeutics(HALO) stock moved between $47.50 at its lowest and $79.50 at its peak.
HALO News
In December 2025, Halozyme Therapeutics announced a global collaboration and exclusive license agreement granting Takeda access to its ENHANZE drug delivery tec...
